GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Price-to-Funds-From-Operations

HUMDF (Hua Medicine) Price-to-Funds-From-Operations : (As of Apr. 24, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Hua Medicine Business Description

Traded in Other Exchanges
Address
Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.